Breakthrough vaccine for deadliest skin cancer reportedly cuts risk by almost half
What happened
According to a Washington Post headline, a vaccine for the deadliest form of skin cancer, melanoma, has reportedly cut the risk of the disease by almost half. The headline is the only detail available here, so the size of the effect and the study design are unknown.
When it started
The Washington Post article's web address indicates it was published on October 22, 2026. Full coverage may give a different timeline for the underlying research.
How it spread
The available material does not explain how the vaccine works, who was studied, or how the risk reduction was measured. Readers should check the original article for these details.
Why it matters
Melanoma is widely described as the most dangerous skin cancer, so a reported reduction in risk is drawing attention. Any claim of this kind should be read in the context of the full study and its limitations.